May 3, 2021

EXINI Diagnostics AB, a Lantheus Company, Receives CE Mark Clearance for aPROMISE in Europe

NORTH BILLERICA, Mass.–(BUSINESS WIRE)–EXINI Diagnostics AB, a subsidiary of Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence (AI) solutions to Find, Fight and Follow serious medical conditions, announced today that it has received CE Mark clearance for aPROMISE in Europe. aPROMISE is artificial intelligence-based, deep learning-enabled, medical device sof

Leave Comment

Your Name *
Your Email *
Your Website
Comment *